HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microsequencing evidence for the maturation of human proopiomelanocortin into an 18 amino acid beta-melanocyte stimulating hormone [h beta MSH(5-22)] in nonpituitary tissue.

Abstract
Sixty pmoles of a material with molecular size, immunological, and RP-HPLC characteristics identical to that of h beta MSH(5-22) were purified from a bronchial carcinoid tumor responsible for the ectopic ACTH syndrome. The first 16 cycles of microsequencing revealed the following sequence: Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-X-Phe-Arg-Trp-Gly-X-Pro- Pro-, identical to the first 16 amino acids of h beta MSH(5-22). Since this material was recognized by an antibody which requires the free COOH-terminal Asp22 residue, it can be assumed that it is indeed h beta MSH(5-22). We also show that neither the 5 N acetic acid nor the 1 N HCl extraction procedure artefactually generated h beta MSH-like material in normal or tumoral human pituitaries and in nonpituitary tumors. We conclude that h beta MSH(5-22) is a normal maturation product of proopiomelanocortin in the human nonpituitary tissues which express its gene, including the hypothalamus and ACTH-secreting tumors.
AuthorsX Bertagna, N Seidah, J F Massias, F Lenne, J P Luton, F Girard, M Chretien
JournalPeptides (Peptides) 1989 Jan-Feb Vol. 10 Issue 1 Pg. 83-7 ISSN: 0196-9781 [Print] United States
PMID2748427 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptide Fragments
  • MSH, beta, (5-22)
  • Pro-Opiomelanocortin
  • Melanocyte-Stimulating Hormones
Topics
  • Amino Acid Sequence
  • Carcinoma, Bronchogenic (analysis)
  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Humans
  • Lung Neoplasms (analysis)
  • Melanocyte-Stimulating Hormones
  • Molecular Sequence Data
  • Peptide Fragments
  • Pituitary Neoplasms (analysis)
  • Pro-Opiomelanocortin (isolation & purification)
  • Radioimmunoassay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: